Comparison of the Effectiveness of Bovilis J5 with Two Other Commercially Available Vaccines Labeled Against Coliform Mastitis
Principal Investigator: Daryl Nydam
Public & Ecosystem Health
Sponsor:
Merck & Company
Grant Number:
MS-Bovilis J5-01-23
Title:
Comparison of the Effectiveness of Bovilis J5 with Two Other Commercially Available Vaccines Labeled Against Coliform Mastitis
Project Amount:
$30,000
Project Period:
January 2025
to
June 2025
DESCRIPTION (provided by applicant):
With these extra funds we will finish enrolling cows to meet the study power estimations, on-farm data collection, and begin data analysis. The objective of trial is to evaluate three commercially available vaccines using labeled dosing, including the Bovilis J5 (Merck Animal Health) using 3 doses, Endovac-Dairy (Endovac Animal Health) using 2 doses, and J-VAC (Boehringer Ingelheim) using 2 doses on important outcomes associated with clinical mastitis in dairy cows.